Tag Archives: Goldman Sachs

Stocks close further in virus vaccine progress

Stocks ended Wednesday on the upside with the news that a candidate Coronavirus vaccine from Moderna (MRNA) – Get report produced the desired immune response and that group Goldman Sachs (GS) – Get report posted stronger earnings than expected. Optimism was somewhat affected by reports that China promised to retaliate …

Read More »

Goldman Sachs’ second-quarter earnings beat estimates as trading desks drive revenue growth

Goldman Sachs reported second-quarter earnings on Wednesday morning that exceeded earnings and earnings analysts’ estimates. Quarterly revenue posted its second highest reading as commercial companies increased due to increased market volatility. Reserves for credit losses reached $ 1.6 billion as the company prepared for the consequences of the credit market. …

Read More »